Anti-ADAMTS-8 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody targeting the carboxyterminal region of ADAMTS-8, validated for Western blot in human tissue and cell lysates.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
UniProt
Q9UP79
Size
100ug
Cat. #
RP1ADAMTS8

In stock

SKU
RP-ADAMTS8

Options

As low as: $130.00

Target Overview

ADAMTS-8 (a disintegrin and metalloproteinase with thrombospondin motifs 8, UniProt Q9UP79) is a secreted metalloprotease belonging to the ADAMTS superfamily, characterized by a pro-domain, catalytic metalloprotease domain, disintegrin-like domain, and multiple thrombospondin type-1 repeats. The 889-amino acid enzyme (EC 3.4.24.-) is secreted into the extracellular matrix where it exhibits anti-angiogenic properties. Originally identified as METH-2 and METH-8, ADAMTS-8 functions in extracellular matrix remodeling and has been implicated in vascular biology, tissue repair, and tumor microenvironment regulation. Its proteolytic activity contributes to matrix turnover during developmental processes and pathological conditions including fibrosis, cardiovascular disease, and cancer progression. Researchers studying angiogenesis inhibition, extracellular matrix dynamics, or protease-mediated signaling pathways frequently examine ADAMTS-8 expression and localization in tissue samples and cell culture models.

Background

ADAMTS-8 belongs to a family of zinc-dependent metalloproteases that cleave extracellular matrix components and regulate cell-matrix interactions. Its anti-angiogenic function positions it as a negative regulator of blood vessel formation, with relevance to both physiological tissue remodeling and pathological neovascularization. The enzyme's localization to the extracellular matrix allows it to influence cellular behavior through both proteolytic and non-proteolytic mechanisms, including direct interaction with cell surface receptors and modulation of growth factor bioavailability. Recent studies have expanded understanding of ADAMTS-8 beyond vascular biology. Ren et al. (2026) demonstrated that miR-1290/ADAMTS8 signaling influences hypertrophic scar formation, suggesting a role in wound healing and fibrotic responses. Klimczak et al. (2026) identified alterations in ADAMTS-8 expression within the hippocampus and prefrontal cortex of patients with major depressive disorder, implicating extracellular matrix remodeling in neuropsychiatric pathology. In oncology, ADAMTS-8 has emerged as a component of prognostic gene signatures: Babas et al. (2026) incorporated extracellular matrix protease transcripts including ADAMTS-8 into machine learning models for breast cancer survival prediction, while Liu et al. (2026) integrated ADAMTS-8 into immune landscape profiling of gastric cancer. Tian et al. (2026) explored ADAMTS-8 as a diagnostic biomarker for acute aortic dissection, developing a multi-marker score combining D-dimer and ADAMTS-8 levels. This cardiovascular application reflects the protease's involvement in arterial wall integrity and matrix degradation during vascular emergencies. Triple Point Biologics offers four rabbit polyclonal antibodies targeting the carboxyterminal region of ADAMTS-8, validated in human samples with predicted cross-reactivity to mouse, rat, primate, and canine orthologs.

References

  1. Ren Y et al (2026) Resveratrol may mitigate the proliferation and migration of hypertrophic scars via miR-1290/ADAMTS8. Xenobiotica. PubMed · DOI
  2. Klimczak P et al (2026) Alterations in gene expression and protein levels of extracellular matrix-related molecules in major depressive disorder: Insights from analyses in the hippocampus and prefrontal cortex. Neurobiol Dis. PubMed · DOI
  3. Babas R et al (2026) Integrative Survival Prediction in Breast Cancer Using Extracellular Matrix Protease Transcript Signatures and Clinical Variables: A Machine Learning Approach. Cancers (Basel). PubMed · DOI
  4. Tian T et al (2026) A D-dimer and ADAMTS8 based multi-marker score for the diagnosis of acute aortic dissection. Sci Rep. PubMed · DOI
  5. Liu L et al (2026) Prognostic integration of tumor microenvironment and parthanatos-related genes in gastric cancer: a machine learning-driven risk model and immune landscape profiling. Front Immunol. PubMed · DOI

Additional Specifications

Gene Symbol ADAMTS8
UniProt ID Q9UP79
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey, Dog
Pack Size 100ug
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 839-889.
Immunogen (Aminoterminal region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 214-264.
Immunogen (Aminoterminal end of propetide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 27-47.
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 219-429.
Alternate Names A disintegrin and metalloproteinase with thrombospondin motifs 8, ADAM-TS 8, ADAM-TS8, ADAMTS-8, METH-2, METH-8, EC 3.4.24.-

Frequently Asked Questions

What is the expected molecular weight for ADAMTS-8 on Western blot?

Full-length ADAMTS-8 has a predicted molecular weight of approximately 103 kDa based on its 889-amino acid sequence. However, as a secreted protease with extensive post-translational modifications including glycosylation, the apparent molecular weight on SDS-PAGE typically ranges from 110-120 kDa. You may also detect processed forms or fragments depending on sample type, since ADAMTS-8 undergoes proteolytic maturation after secretion. Conditioned media from cells expressing ADAMTS-8 often show multiple bands corresponding to the proenzyme, mature enzyme, and cleavage products. For initial experiments, expect the major band between 110-120 kDa in cell lysates and conditioned medium.

What starting dilution should I use for ADAMTS-8 Western blot?

We recommend starting at 1:1000 for Western blot with overnight incubation at 4°C. This dilution has been validated with human samples. Because ADAMTS-8 is a secreted protein, signal intensity varies significantly between cell lysates and conditioned media. Conditioned medium often requires less antibody; you may achieve good signal at 1:2000. If working with tissue lysates where ADAMTS-8 expression is low, start at 1:500 and titrate upward. Always include a positive control such as conditioned medium from HT1080 or A549 cells, which express detectable endogenous ADAMTS-8.

Does this antibody work for mouse and rat ADAMTS-8?

The antibody is validated for human ADAMTS-8. Reactivity with mouse and rat is predicted based on sequence homology but not experimentally validated by Triple Point Biologics. Human and mouse ADAMTS-8 share approximately 75% identity across the full protein, with higher conservation in the catalytic domain. If working with rodent samples, plan to empirically test the antibody starting at the recommended 1:1000 dilution. Include a human positive control in parallel. Researchers have reported variable success with cross-species detection of ADAMTS family members, so pilot experiments are essential before committing to large-scale studies.

Should I use conditioned medium or cell lysate for detecting ADAMTS-8?

Because ADAMTS-8 is a secreted metalloprotease, conditioned medium is generally the preferred sample type and provides stronger, cleaner signal than cell lysate. Cells secrete ADAMTS-8 into the extracellular space where it associates with matrix components. To prepare conditioned medium, culture cells in serum-free or low-serum medium for 24-48 hours, collect supernatant, clarify by centrifugation, and concentrate 10-20-fold using centrifugal filters (10 kDa cutoff). Whole-cell lysates contain primarily intracellular proenzyme. For adherent cells producing extracellular matrix, consider extracting matrix-associated ADAMTS-8 using chaotropic agents after removing cells.

Can this antibody distinguish between pro-ADAMTS-8 and the mature enzyme?

This polyclonal antibody recognizes epitopes across ADAMTS-8 and will detect both the proenzyme and mature, processed forms. It does not selectively recognize only the pro-domain or only the mature catalytic domain. On Western blot you may observe multiple bands representing the full-length proenzyme, the mature enzyme after pro-domain removal, and further proteolytic fragments. The banding pattern provides information about processing state but the antibody itself does not discriminate between forms. If you need to specifically detect activation state, consider combining this antibody with functional assays or using samples treated with protease inhibitors to preserve the proenzyme.

What positive and negative controls should I use for ADAMTS-8 experiments?

For positive controls, use conditioned medium from cell lines with documented ADAMTS-8 expression such as HT1080 fibrosarcoma or A549 lung carcinoma cells. Alternatively, recombinant human ADAMTS-8 protein serves as a defined positive control for validating antibody performance and confirming expected molecular weight. For negative controls, use medium alone or conditioned medium from cells with negligible ADAMTS-8 expression. Cell lines treated with the translation inhibitor cycloheximide provide additional specificity controls. Include molecular weight markers spanning 75-150 kDa. For IHC, normal tissues with low ADAMTS-8 expression (such as normal liver) serve as useful negative references.

Are there known ADAMTS-8 isoforms I should be aware of?

The primary annotated isoform of ADAMTS-8 (UniProt Q9UP79-1) is 889 amino acids. Alternative splicing has been reported but validated functional isoforms are not well-characterized in the literature compared to other ADAMTS family members. Most published work focuses on the full-length secreted form. You may observe multiple bands on Western blot, but these typically represent post-translational processing (furin cleavage of the pro-domain, glycosylation heterogeneity, or extracellular proteolytic cleavage) rather than splice variants. If working with tissue samples or complex biological fluids, expect heterogeneous banding due to processing rather than true isoform diversity.

How should I store this ADAMTS-8 antibody and what is the shelf life?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase background. The antibody is supplied as a rabbit polyclonal in a buffered solution, typically stable for at least 12 months at -20°C. Once thawed, an aliquot can be stored at 4°C for up to one month for convenience during active experiments. Do not store diluted antibody; prepare working dilutions fresh in blocking buffer immediately before use. If you observe increased background or reduced signal over time, this often indicates degradation from repeated temperature cycling rather than expiration of properly stored stock.

Western blot validation for RP-ADAMTS8 — 1 panel across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

ADAMTS-8: Metalloproteinase domain — WB validation
WB · Panel 1 ADAMTS-8: Metalloproteinase domain

Custom validation studies available on request — contact us.

Also known as:

  • A disintegrin and metalloproteinase with thrombospondin motifs 8
  • ADAM-TS 8
  • ADAM-TS8
  • ADAMTS-8
  • METH-2
  • METH-8
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →